Citigroup’s Akcea Therapeutics, Inc. Common Stock AKCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-220,124
| Closed | -$3.99M | – | 5412 |
|
|
2020
Q3 | $3.99M | Buy |
220,124
+204,717
| +1,329% | +$3.71M | ﹤0.01% | 1200 |
|
|
2020
Q2 | $211K | Buy |
15,407
+5,849
| +61% | +$80.1K | ﹤0.01% | 3053 |
|
|
2020
Q1 | $137K | Sell |
9,558
-621
| -6% | -$8.9K | ﹤0.01% | 3093 |
|
|
2019
Q4 | $172K | Buy |
10,179
+4,862
| +91% | +$82.2K | ﹤0.01% | 3228 |
|
|
2019
Q3 | $82K | Sell |
5,317
-27,131
| -84% | -$418K | ﹤0.01% | 3539 |
|
|
2019
Q2 | $761K | Sell |
32,448
-1,658
| -5% | -$38.9K | ﹤0.01% | 2369 |
|
|
2019
Q1 | $966K | Buy |
34,106
+22,806
| +202% | +$646K | ﹤0.01% | 1996 |
|
|
2018
Q4 | $341K | Buy |
11,300
+8,720
| +338% | +$263K | ﹤0.01% | 2774 |
|
|
2018
Q3 | $90K | Buy |
+2,580
| New | +$90K | ﹤0.01% | 3674 |
|
|
2018
Q2 | – | Sell |
-125
| Closed | -$3K | – | 5152 |
|
|
2018
Q1 | $3K | Sell |
125
-4
| -3% | -$96 | ﹤0.01% | 4723 |
|
|
2017
Q4 | $2K | Buy |
+129
| New | +$2K | ﹤0.01% | 4842 |
|